Approval for Pharmanet Group to acquire Keras Gold

RNS Number : 5802G

Keras Resources PLC

30 May 2017

 

Keras Resources plc / Index: AIM / Epic: KRS / Sector: Mining

30 May 2017

Keras Resources plc ('Keras' or 'the Company')

Approval by Shareholders of Pharmanet Group to acquire Keras Gold

Keras Resources plc, the AIM listed mineral resource company is pleased to advise that shareholders of Pharmanet Group Limited ("Pharmanet") have approved all the resolutions associated with the acquisition of 100% of the issued share capital of the Company's wholly owned subsidiary Keras (Gold) Australia Pty Ltd ("Keras Australia") at a general meeting of shareholders held today in Perth, Australia.

A copy of the announcement made by Pharmanet can be accessed using the following link http://www.asx.com.au/asxpdf/20170530/pdf/43jlxy6z4hr4wf.pdf

Completion of the fund raising by Pharmanet and listing of Calidus Resources Limited is still anticpated by mid-June subject to final ASX regulatory approvals.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

**ENDS**

For further information please visit www.kerasplc.com, follow us on Twitter @kerasplc or contact the following:

Dave Reeves	Keras Resources plc	[e-mail]
Nominated Adviser
Gerry Beaney/David Hignell	Northland Capital Partners Limited	[phone]
Broker
Elliot Hance/Jonathon Belliss Damon Heath/Erik Woolgar	Beaufort Securities Limited Shard Capital Partners LLP	[phone] [phone]
Tom Curran/Ben Tadd	SVS Securities Plc	[phone]
Financial PR
Susie Geliher/Charlotte Page	St Brides Partners Limited	[phone]

 

END

 

 

MSCEAFSEDDDXEFF